P/E Ratio (TTM)
-28.32
Financial Fundamentals
DRUG • Quarterly Data • 5Y View
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2019-12-31 | -393.88 |
| 2020-03-31 | -2014.41 |
| 2020-06-30 | -307.74 |
| 2020-09-30 | -32.36 |
| 2020-12-31 | -16.42 |
| 2021-03-31 | -6.02 |
| 2021-06-30 | -4.53 |
| 2021-09-30 | -9.33 |
| 2021-12-31 | -2.49 |
| 2022-03-31 | -1.22 |
| 2022-06-30 | -1.12 |
| 2022-09-30 | -2.18 |
| 2022-12-31 | -1.92 |
| 2023-03-31 | -1.33 |
| 2023-06-30 | -2.59 |
| 2023-09-30 | -1.33 |
| 2023-12-31 | -1.21 |
| 2024-03-31 | -2.88 |
| 2024-06-30 | 6.70 |
| 2024-09-30 | -2.12 |
| 2024-12-31 | 1603.28 |
| 2025-03-31 | -31.11 |
| 2025-06-30 | -12.18 |
| 2025-09-30 | -37.01 |
| 2025-12-31 | -28.32 |
* P/E ratios are calculated using trailing twelve-month (TTM) earnings.